Astec LifeSciences Limited (ASTEC) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.036x

Based on the latest financial reports, Astec LifeSciences Limited (ASTEC) has a cash flow conversion efficiency ratio of -0.036x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-83.99 Million ≈ $-908.28K USD) by net assets (Rs2.35 Billion ≈ $25.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Astec LifeSciences Limited stock valuation for the company's overall valuation and market capitalisation.

Astec LifeSciences Limited - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Astec LifeSciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Astec LifeSciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Astec LifeSciences Limited ranked by their cash flow conversion efficiency. Explore Astec LifeSciences Limited cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Vestel Elektronik Sanayi ve Ticaret AS
IS:VESTL
0.049x
Amaero Ltd
AU:3DA
-0.190x
Shangri-La Hotel Public Company Limited
BK:SHANG
0.013x
Laguna Resorts & Hotels Public Company Limited
BK:LRH
0.012x
Kolibri Global Energy Inc
TO:KEI
0.033x
BV Financial, Inc. Common Stock
NASDAQ:BVFL
0.019x
Aplicaciones y Tratamiento de Sistemas S.A.
MC:ATSI
0.029x
Sparebank 1 Nordvest
OL:SNOR
-0.029x

Annual Cash Flow Conversion Efficiency for Astec LifeSciences Limited (2008–2025)

The table below shows the annual cash flow conversion efficiency of Astec LifeSciences Limited from 2008 to 2025. View current stock price of Astec LifeSciences Limited for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs2.35 Billion
≈ $25.42 Million
Rs-83.99 Million
≈ $-908.28K
-0.036x -229.20%
2024-03-31 Rs3.70 Billion
≈ $39.96 Million
Rs102.21 Million
≈ $1.11 Million
0.028x -84.46%
2023-03-31 Rs4.20 Billion
≈ $45.37 Million
Rs746.56 Million
≈ $8.07 Million
0.178x +199.02%
2022-03-31 Rs3.97 Billion
≈ $42.90 Million
Rs236.04 Million
≈ $2.55 Million
0.060x +325.51%
2021-03-31 Rs3.09 Billion
≈ $33.45 Million
Rs-81.62 Million
≈ $-882.72K
-0.026x -103.87%
2020-03-31 Rs2.47 Billion
≈ $26.70 Million
Rs1.68 Billion
≈ $18.22 Million
0.682x +805.15%
2019-03-31 Rs2.03 Billion
≈ $21.93 Million
Rs152.85 Million
≈ $1.65 Million
0.075x -80.20%
2018-03-31 Rs1.70 Billion
≈ $18.38 Million
Rs646.75 Million
≈ $6.99 Million
0.381x +173.44%
2017-03-31 Rs1.38 Billion
≈ $14.94 Million
Rs192.32 Million
≈ $2.08 Million
0.139x +401.11%
2016-03-31 Rs1.17 Billion
≈ $12.65 Million
Rs-54.05 Million
≈ $-584.56K
-0.046x -137.74%
2015-03-31 Rs1.35 Billion
≈ $14.64 Million
Rs165.82 Million
≈ $1.79 Million
0.122x -21.96%
2014-03-31 Rs1.14 Billion
≈ $12.28 Million
Rs178.19 Million
≈ $1.93 Million
0.157x +1.12%
2013-03-31 Rs1.06 Billion
≈ $11.45 Million
Rs164.31 Million
≈ $1.78 Million
0.155x +77.15%
2012-03-31 Rs987.06 Million
≈ $10.67 Million
Rs86.48 Million
≈ $935.23K
0.088x -48.14%
2011-03-31 Rs970.25 Million
≈ $10.49 Million
Rs163.91 Million
≈ $1.77 Million
0.169x +50.01%
2010-03-31 Rs931.08 Million
≈ $10.07 Million
Rs104.85 Million
≈ $1.13 Million
0.113x +252.98%
2009-03-31 Rs325.25 Million
≈ $3.52 Million
Rs-23.94 Million
≈ $-258.93K
-0.074x -109.22%
2008-03-31 Rs229.75 Million
≈ $2.48 Million
Rs183.53 Million
≈ $1.98 Million
0.799x --

About Astec LifeSciences Limited

NSE:ASTEC India Agricultural Inputs
Market Cap
$175.11 Million
Rs16.19 Billion INR
Market Cap Rank
#17155 Global
#903 in India
Share Price
Rs726.70
Change (1 day)
-3.77%
52-Week Range
Rs521.85 - Rs918.75
All Time High
Rs2248.18
About

Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maiz… Read more